And it has been demonstrated that miR-32-5p, delivered by drug-resistant cellular exosomes activates the PI3K/Akt pathway, which leads to multidrug resistance in hepatocellular carcinoma through angiogenesis and EMT, and becomes another obstacle to hepatocellular carcinoma treatment (22). Here, AKT1 is linked to hepatocellular carcinoma.